A groundbreaking study by researchers from Charles Darwin University (CDU) and the Royal Melbourne Institute of Technology (RMIT) has revealed that a specific cannabis extract, known as PHEC-66, has a “deadly” effect on melanoma cells in laboratory settings. Published in the Cells journal, the study highlights how PHEC-66 induces apoptosis, or programmed cell death, in melanoma cells, offering a potential new avenue for treatment.

Melanoma, although accounting for only 6% of skin cancers, is responsible for over 80% of skin cancer deaths. Current treatments often come with significant side effects and limited effectiveness. The natural properties of cannabis could provide a less harmful alternative. However, researchers caution that further studies, including animal trials, are necessary to ensure safety and efficacy before human trials can commence.

For more details, you can read the full article on ABC News here.